Use of oral isotretinoin to treat acne in the public system: a hospital-based retrospective cohort
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Acne needs to be treated early to prevent negative psychosocial impacts. In severe or moderate forms, which tend to leave scars, oral isotretinoin is the first-line therapy. However, concern about its adverse events, especially in developed countries, delays effective treatment. In contrast, isotretinoin is widely prescribed in Brazilian private clinics. OBJECTIVES: To describe the use of isotretinoin for treating acne in a Brazilian public hospital, and to analyze whether its prescription is effective or belated. DESIGN AND SETTING: Retrospective cohort study in a public hospital. METHODS: Clinical and therapeutic data were obtained from the medical records of patients who were undergoing or had undergone acne treatment with isotretinoin in this hospital's general dermatology outpatient clinic over the last seven years, up to April 2018. RESULTS: 1526 medical records from patients with acne were analyzed. Isotretinoin was prescribed for 279 patients (18.28%) with mild (1.19%), moderate (57.37%), severe (35.85%) or conglobata (5.57%) forms of acne vulgaris. Sequelae of acne were present at the start of most of these patients' treatment. An initial daily dose of 20 mg was usually prescribed. The average initial dose/weight ratio was 0.33 mg/kg/day. The average total dose/weight ratio was 127.61 mg/kg. There were only a few cases of laboratory abnormalities. CONCLUSION: Sequelae of acne at the onset of treatment reveal delayed indication of isotretinoin, which can have negative psychosocial impacts on quality of life. Isotretinoin should be indicated early to prevent this. Its use is supported by its lack of laboratory alterations and controllable adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Data from 2 isotretinoin cohort studies estimated the risk of mild normocytic anemia as 0.4%, abnormal platelet level at 1.2% to 2.9%, and abnormal white blood cell count at 7.0% to 10.8%”
From Guidelines of care for the management of acne vulgaris (2024) · cites this paper as [269]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The hidden cost of skin scars: quality of life after skin scarring
Brown, B. C., McKenna, S. P., Siddhi, K., McGrouther, D. A., & Bayat, A. (2008) · Journal of Plastic, Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2008.03.020 · Cited by 515
Halvorsen, J. A., Stern, R. S., Dalgard, F., Thoresen, M., Bjertness, E., & Lien, L. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.264 · Cited by 426
Thiboutot, D. M., Dréno, B., Abanmi, A., Alexis, A. F., Araviiskaia, E., Barona Cabal, M. I., Bettoli, V., Casintahan, F., Chow, S., da Costa, A., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.09.078 · Cited by 418 · cited 4×
“2019; 137(4):363-8 Other previously reported adverse events that have been matters of controversy, such as depression, suicidal ideation and inflammatory bowel disease, have not been correlated with use of the drug, but with acne itself and not with any treatment.”
BackgroundResultInfluentialRecent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris
White, G. M. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70442-6 · Cited by 334
The psychological and emotional impact of acne and the effect of treatment with isotretinoin
KELLETT, & GAWKRODGER (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02662.x · Cited by 306
Self-esteem and body satisfaction among late adolescents with acne: Results from a population survey
Dalgard, F., Gieler, U., Holm, J. Ø., Bjertness, E., & Hauser, S. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.07.013 · Cited by 218
Roaccutane Treatment Guidelines: Results of an International Survey
Cunliffe, W. J., van de Kerkhof, P. C. M., Caputo, R., Cavicchini, S., Cooper, A., Fyrand, O. L., Gollnick, H., Layton, A. M., Leyden, J. J., Mascaró, J.-M., et al. (2009) · Dermatology · doi:10.1159/000246134 · Cited by 197
Recent Advances in Acne Pathogenesis: Implications for Therapy
Das, S., & Reynolds, R. V. (2014) · American Journal of Clinical Dermatology · doi:10.1007/s40257-014-0099-z · Cited by 185
Margolis, D. J., Fanelli, M., Hoffstad, O., & Lewis, J. D. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.303 · Cited by 177
Adverse effects of isotretinoin: A large, retrospective review
Brzeziński, P., Borowska, K., Chiriac, A. E., & Śmigielski, J. (2017) · Dermatologic Therapy · doi:10.1111/dth.12483 · Cited by 177
Cited by
Guidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
Greydanus, D. E., Azmeh, R., Cabral, M. D., Dickson, C. A., & Patel, D. R. (2020) · Disease-a-Month · doi:10.1016/j.disamonth.2020.101103 · Cited by 84
Demirbaş, A., Demirbaş, G. U., Diremsizoğlu, E., & İslamoğlu, Z. G. K. (2025) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70108 · Cited by 10
“Previous studies have identified concerns about the side effects of isotretinoin, patient hesitation, and clinician reluctance as common reasons for delayed systemic treatment [3, 17].”
Assessment of quality of life in patients with severe acne
Gryazeva, N. V., & Вардановна, Т. А. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-9-12-15 · Cited by 2
Batista, C. C. M., Lopes, L. R. S., Lopes, L. P. S., & Lopes, I. M. R. S. (2022) · Research Society and Development · doi:10.33448/rsd-v11i5.27533 · Cited by 1
Metadata
- Authors
- Evaristo, L. S. B. F., & Bagatin, E.
- Affiliations
- Universidade Federal de São Paulo (BR)
- Corresponding author
- Bagatin, Ediléia
- Venue
- Sao Paulo Medical Journal
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2019-07
- Volume
- 137
- Issue
- 4
- Pages
- 363-368
- ISSN
- 0035-0362 (ISSN-L)
- 1806-9460
- 1516-3180
- PMC
- PMC9744014
- OpenAlex
- W2982523154
- Cited by
- 11
- References
- 35
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 1
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Sao Paulo Medical Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- isotretinoin, acne, treatment delay, public hospitals, prescribing patterns, adverse events, psychosocial impact, quality of life
- MeSH terms
- Acne Vulgaris, Adult, Female, Hospitals, Public, Humans, Male, Retrospective Studies, Severity of Illness Index, Cohort Studies, Isotretinoin, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of oral isotretinoin to treat acne in the public system: a hospital-based retrospective cohort. https://app.cochat.ai/papers/10.1590/1516-3180.2018.054405072019
- The paper
- Evaristo, L. S. B. F., & Bagatin, E. (2019). Use of oral isotretinoin to treat acne in the public system: a hospital-based retrospective cohort. Sao Paulo Medical Journal. https://doi.org/10.1590/1516-3180.2018.054405072019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.